What KT Innovations does

KT Innovations, doing business as KT Cath, is a pre-revenue medical device company developing an external male urinary catheter intended to address failure modes of current condom catheter solutions. The company was founded by Katelyn Holt, RN BSN, an experienced nurse who designed the device after observing catheter failures, incontinence-related skin breakdowns (ulcers), and catheter-associated urinary tract infections (CAUTIs) leading to blood infections during her clinical career. The KT Cath holds a US Utility Patent awarded in June 2020, with an additional patent pending as of March 2025, and a working proof of concept has been developed in partnership with Nova Design in Providence. The device targets male incontinence as a first-line defense in institutional care settings.

The commercial model is B2B medical device sales to hospitals, skilled nursing facilities, and outpatient settings, with a planned product launch in 2026. Pricing has not been publicly disclosed and no customers have been signed. Distribution is planned via direct enterprise sales to healthcare facilities, potentially supplemented by medical device distributors. The company has received only $17,000 in grant funding plus in-kind services from the NEMIC Accelerator Program (2023), and has been admitted to the MassChallenge U.S. Early Stage cohort (July 2023), the NEMIC Med Tech Leadership program, and the RIHub Venture Mentoring Service.

Operationally, KT Innovations is a founder-led, single-employee company supplemented by an advisory board of medtech executives, regulatory quality experts, and venture mentors. The company has generated earned media in the Boston Globe, Radio Entrepreneurs, NEMIC Spotlight, and Providence Business News, and has won the NEMIC Med Tech Leadership first-place pitch (2023) and the RI Business Competition. Critical pre-commercial milestones — particularly FDA regulatory pathway completion and any commercial sales — have not yet been evidenced in available sources.

Name

KT Innovations

Legal name

KOLT INNOVATIONS, INC

Website

https://ktcath.com

Company type

Private

Founded year

2023

Operating status

Operating

Ownership category

akta.pro rank

Product category

Medical Devices (Urological/Continence Care)

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement) (HLAHALAI)

akta.pro secondary industries

Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH), Continence Care Products (Adult Incontinence Pads/Briefs, Underpads, External Collectors) (HLAHALAH)

Keywords

• Medical devices
• External urinary catheter
• Incontinence care
• Urology devices
• Male catheter

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: Hardware sales of the KT Cath external male urinary catheter to healthcare institutions including hospitals, skilled nursing facilities, and outpatient settings. Product launching in 2026.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

KT Innovations (doing business as KT Cath) designs and develops an external male urinary catheter intended as a functional and dependable alternative to condom catheters. The device targets hospitals, skilled nursing facilities, and outpatient settings for male incontinence care, with the explicit aim of preventing catheter-associated urinary tract infections (CAUTIs) and skin breakdown (ulcers) caused by incontinence briefs. The product is currently in R&D with prototypes and is scheduled for commercial launch in 2026.

Product overview

KT Innovations (doing business as KT Cath) is a single-product medical device company. The company offers the KT Cath, a revolutionary external male urinary catheter currently in development. The product is designed as a first line of defense against male incontinence in hospitals, skilled nursing facilities, and outpatient settings. The company is led by founder Katelyn Holt, RN BSN, who developed the device based on her decade of nursing experience witnessing failures of existing catheter solutions. The company is currently in the R&D phase with prototypes and has received a US Utility Patent (awarded June 2020) with another patent pending as of March 2025. Commercial launch is targeted for 2026.

Differentiator

Problem solved

Functional benefit

Products and services

• KT Cath External Male Urinary Catheter External male urinary catheter device designed as a functional and dependable alternative to condom catheters for male incontinence care. Targets hospitals, skilled nursing facilities, and outpatient settings, and is intended to prevent Catheter Associated Urinary Tract Infections (CAUTIs) and skin breakdown (ulcers) caused by incontinence briefs.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core and minor.

• MassChallengecoreStrategic or Co-development Partner · 1 July 2023Selected from 1,700 applications as one of 150 companies for the MassChallenge U.S. Early Stage cohort beginning July 2023. MassChallenge is a prestigious startup accelerator program providing mentorship and resources.
• NEMIC (New England Medical Innovation Center)coreStrategic or Co-development Partner · 25 April 2023NEMIC provided the intensive 6-month Med Tech Leadership course and accepted KT Innovations into their Accelerator Program. They also received $17,000 grant and in-kind services from Med Tech experts. NEMIC continues to provide ongoing advisory support.
• RIHubcoreStrategic or Co-development PartnerRIHub Venture Mentoring Service paired KT Innovations with experts in MedTech and FDA Regulation. They continue to meet monthly. Also provides Customer Discovery Program with Lean Stack methodology.
• Nova DesigncoreStrategic or Co-development PartnerPartnering with Nova Design in Providence for device development. They have a working proof of concept and continue evolution of the KT Cath as funding is secured.
• NEMIC (Expert Advisory Board)minorStrategic or Co-development PartnerNEMIC provides expert advisory board representation including Michael Pereira (COO), Michelle Wu (Executive, Medical Devices), Tom Hutchinson (Regulatory Quality Expert), and Barbara Rosengren (Venture Mentor).

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Coloplast: Danish global medtech with a dedicated ostomy and continence care business that includes external catheters and male incontinence devices sold to hospitals and homecare — directly comparable product category, customer base, and use case to KT Cath.
• Hollister Incorporated: Privately held medtech with a continence care portfolio including external catheters and male incontinence products sold into hospitals and long-term care — same product category and institutional buyer set as KT Cath.
• ConvaTec: Global medtech with continence and ostomy care lines that include external catheters and urological collection products marketed to hospitals, SNFs, and homecare — overlapping product and customer profile with KT Cath.
• Teleflex Incorporated: Public medtech with a urology portfolio that includes external and intermittent catheters sold into hospitals and skilled nursing facilities — comparable urology catheter category and institutional buyers.
• B. Braun: Global medical device manufacturer with a urology and continence care line including external catheter solutions sold to hospitals and long-term care — directly competes in the same catheter category KT Cath is entering.
• Wellspect Healthcare: Subsidiary of Mölnlycke focused on urology products including intermittent and external catheters sold to hospitals and homecare — directly comparable urology catheter product line and clinical buyers.
• Urocare Products: Specialty urology manufacturer focused on external catheters, leg bags, and reusable incontinence products — a niche specialty competitor most directly comparable to KT Cath's external catheter focus.

Broad incumbents

• BD (Becton, Dickinson and Company): Large diversified medtech with a urology and drainage product line that includes urinary collection and catheter products sold to the same hospital buyer set as KT Cath, though as part of a much broader portfolio.
• Cardinal Health: Major medical product distributor and manufacturer with a portfolio that includes urological supplies and continence care products distributed to the hospitals and SNFs that KT Cath targets — comparable channel and customer base.
• Medline Industries: Large privately held medical supply manufacturer and distributor with continence care and urological products sold into hospitals and skilled nursing facilities — comparable institutional customer base and product category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KT Innovations